Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.58 -0.04 (-1.53%)
As of: Aug 21, 2026 · 10:54 AM EDT

Kiora Pharmaceuticals (KPRX) Revenue (2016 - 2024)

Kiora Pharmaceuticals' (KPRX) quarterly Revenue came in at $16.0 million in Q1 2024, up 132580.99% on a QoQ basis from $12059.0 in Q4 2020.

Kiora Pharmaceuticals (KPRX) Revenue (2016 - 2024) Analysis & Trends

Kiora Pharmaceuticals (KPRX) has 6 years of Revenue data on file, last reported at $16.0 million in Q1 2024.

  • Quarterly Revenue changed N/A year-over-year to $16.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $16.0 million (changed N/A YoY) and the FY2024 annual result came in at $16.0 million, changed N/A from the prior year.
  • Revenue rose to $16.0 million in Q1 2024, from $12059.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $16.0 million in Q1 2024 to a low of $12059.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 86.51 Bn 78.51 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 65.74 Bn 60.56 Bn 1.37 Bn 1.52 Bn
4 Moderna 59.39 Bn 54.26 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 42.24 Bn 37.15 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.78 Bn 28.47 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.22 Bn 26.39 Bn - 674.14 Mn
10 Kiora Pharmaceuticals 15.94 Mn 15.94 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 20,000.00
Mar 31, 2024 16.00 Mn
Dec 31, 2020 12,059.00
Mar 31, 2019 2.69 Mn
Sep 30, 2018 314,500.00
Jun 30, 2018 242,012.00
Mar 31, 2018 1.10 Mn
Sep 30, 2017 74,696.00
Jun 30, 2017 148,290.00
Mar 31, 2017 184,532.00
Dec 31, 2016 160,370.00
Sep 30, 2016 274,289.00
Jun 30, 2016 234,600.00